Skip to content

Effect of Kangai No.2 prescription on immune system of patients with advanced colorectal cancer: a randomized controlled study

Effect of Kangai No.2 prescription on immune system of patients with advanced colorectal cancer: a randomized controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003633
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients with stage IV colorectal cancer with definite pathological diagnosis; (2) Patients aged between 18 and 80 years old; (3) There were no serious virus and bacterial infection, no organ failure and serious heart disease; (4) There were no other serious complications; (5) I agreed to participate in the study and signed the informed consent form after being informed, and the compliance was good. (6) There was no allergic reaction to the compatible ingredients in the prescription.

Exclusion criteria

Exclusion criteria: (1) Patients who are receiving other drug intervention treatment (including other Chinese herbal pieces, chemotherapy, targeted drugs); (2) Patients with mental illness themselves, those with lack of autonomous behavior ability, and those with mental disorders have no independent behavior ability; (3) Pregnant, ready for pregnancy or lactation. (4) Combined with heart, lung, brain, liver, kidney and hematopoietic system and other serious diseases, mental patients. (5) Allergic constitution or known allergy to the components of the drug. (6) Patients who are participating in other clinical trials or have participated in other clinical trials within 3 months. (7) Alcoholism and / or psychoactive substances, drug abusers and addicts.

Design outcomes

Primary

MeasureTime frame
survival rate;Tumor recurrence rate;

Countries

China

Contacts

Public ContactZhao Fanchen

Shanghai Municipal Hospital of Traditional Chinese Medicine

wwwzfc@sina.com+86 18918698370

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026